In a new paper published in Science Translational Medicine, Leyden Labs reports landmark preclinical and clinical data supporting the development of their antibody-based nasal sprays to prevent influenza infection by neutralizing virus at portal of entry. The post Leyden Labs Demonstrates Feasibility of Novel Antibody-Based Nasal Spray for Flu Prevention appeared first on Leyden Labs .
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules